Novavax eliminates COO role; John Trizzino to depart June 20, 2025

NOVAVAX INC

COO position eliminated; John Trizzino's employment terminated effective June 20, 2025.
Separation pay of $601,778 lump sum plus up to 12 months COBRA premiums.
Consulting agreement June 20 to Dec 31, 2025 at $15,000/month; equity continues vesting during period.
Unvested options from March 2023 grant will fully vest upon consulting agreement termination.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Trizzino

Chief Operating Officer

NVAX · NOVAVAX INC

Effective: 2025-06-20
Filed: May 27, 2025, 7:59 PM ET

determined to eliminate the position of Chief Operating Officer, and terminate the employment of John Trizzino with the Company effective as of June 20, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Trizzino was terminated as Chief Operating Officer at NOVAVAX INC.

Action: terminated
Role: Chief Operating Officer

Exact text from the filing

determined to eliminate the position of Chief Operating Officer, and terminate the employment of John Trizzino with the Company effective as of June 20, 2025.

View on SEC.gov

NOVAVAX INC filing history →

Source: SEC EDGAR

accession 0001104659-25-052959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.